Third-party tested peptides are research peptides whose lot was analysed by a laboratory independent of both the manufacturer and the seller, with a report the laboratory itself can confirm. The phrase carries information only when five things are stated: which lab, who sent the sample, which lot, which assays, and where the lab’s own record can be found. Without those, “third-party tested” is a description of marketing rather than of testing. This article sets out the five questions, what the phrase can leave out, and how the nine reports in our open lot report dataset answer each one.
This page is about research peptides sold for laboratory work. It does not cover dietary supplements, which use the same phrase under different rules.
Third-party tested: what the claim should cover
| Element | A meaningful claim states | A vague claim can leave out |
|---|---|---|
| The lab | A named laboratory with its own address and contact | No lab name, or an in-house lab described as independent |
| The requester | Who sent the sample: seller, manufacturer or end researcher | That the report was ordered by another company for its own lot |
| The lot | A lot code that matches the vial and a test date | That one report is being stretched across other sizes and later lots |
| The assays | Each test run, with its method | That only purity was measured, or that identity was by retention time only |
| The record | A report number or code that opens the lab’s own copy | That no lab-held record exists at all |
Source: Vortex Research Editorial Team.
Research materials: Vortex Research publishes its third-party lab reports, labelled by who requested each one, at /coa/. The summary values are released as an open dataset, doi:10.5281/zenodo.23578844.
“Third party” means independent of whom?
Quality testing uses a simple numbering. The first party is the maker, testing its own output in its own quality-control lab. The second party is the buyer or the seller, checking what it received. The third party is a laboratory with no stake in the result, hired to measure and report.
Payment does not break independence. Someone always pays for a test, and a lab paid by the seller can still measure honestly. What independence requires is that the lab is a separate business with its own reputation and records, that it reports what it measured whether or not the result is welcome, and that the original report stays in its own system where the seller cannot change it. A report from a lab that shares ownership, staff or premises with the seller is first-party or second-party testing, whatever the label says.
Who sent the sample: the link a lab cannot see
A laboratory tests the container it receives. It does not know where that container came from. ILS Laboratories reports, for example, state that sample names and lot codes are supplied by the submitter. So the strength of a “third-party tested” claim depends heavily on who did the sending.
Three arrangements are common. A seller sends a sample from its own stock. A manufacturing or wholesale facility tests its lot before selling it on, and the seller republishes that report. Or an end researcher sends a sample from a vial already received. Each produces real measurements. What changes is whose word connects the tested sample to the vial on a bench. A claim that does not say which arrangement applies leaves the reader unable to weigh that step.
Accreditation: useful, but read the scope
ISO/IEC 17025 sets out what a competent testing laboratory has to demonstrate, and accreditation against it is granted by an outside body. The certificate comes with a scope: a list of the methods the assessment covered. That list is the part to read. A lab accredited for metals by ICP-MS has not, by that fact, been assessed on its peptide HPLC work, and accreditation never extends to the samples customers send in. A claim of “accredited third-party testing” is complete only when the method on the report falls within the lab’s scope.
Which assays sit behind the word “tested”
“Tested” names no test. For a research peptide, the assays that commonly appear on a report answer different questions, and a report can carry any subset of them.
- Purity by RP-HPLC: the share of detected peak area belonging to the main component. It does not prove what that component is. Our explainer on HPLC peptide purity covers how the figure is calculated.
- Identity: by mass spectrometry, which compares a measured mass with the mass calculated from the sequence [1], or by HPLC retention time against a reference standard, which is quicker but weaker because two molecules can elute close together. Specifications for peptide substances list identity, purity and content as separate attributes for this reason [2].
- Net content: how much material is in the vial, against the labelled fill.
- Contaminant tests: endotoxin, sterility screening and metals, where someone ordered them. These describe the tested sample as laboratory data. Our explainer on endotoxin testing covers how one of them is read.
Purity results also depend on the method. Column chemistry and solvent choice change how well a reversed-phase separation resolves related peptides [3], and synthetic peptides carry several classes of related impurity that a single method may not separate [4]. A complete claim names the method next to each result.
Lot match and dates: when a claim goes stale
A report describes one lot on one date. A product page does not expire the same way. Once a lot sells through, the next lot arrives with a new code, and a “third-party tested” badge that still points to the old report now describes material that is no longer on the shelf. Two checks catch this: the lot code on the report should match the lot printed on the vial or its paperwork, and the test date should fit the age of the stock on sale. A claim that does not name a lot cannot be checked against either.
What “third-party tested” can hide
None of these is unusual, and each one leaves the phrase technically true:
- One report, for one size or one lot, used to support a claim across a whole catalogue.
- A report from a lot that has already sold through.
- Purity measured, identity not measured, or identity by retention time only.
- A report ordered by a manufacturing facility for its own lot, presented as if the seller ordered it.
- Selective ordering: the tests most likely to look good are run, and the rest are not.
- “Third-party verified” meaning a person reviewed paperwork, with no laboratory measurement at all.
- Results quoted on a product page with no report anyone can open.
- A lab that has no independent website, address or record system.
Spotting an edited or reused report is a separate job; our walkthrough of a peptide COA covers the document itself.
Five questions to test any third-party tested claim
- Which lab? Is it named, and does it exist independently of the seller?
- Who sent the sample? The seller, a manufacturing facility or an end researcher?
- Which lot, and when? Does the lot code match the vial, and is the test date plausible for current stock?
- Which assays, by which method? In particular, is identity by mass spectrometry or by retention time?
- Where is the lab’s record? Can the report be opened on the lab’s own domain, and does every field match the seller’s copy?
A claim that answers all five is a specific, checkable statement. A claim that answers none is a slogan.
How our nine reports answer the five questions
We apply the same questions to the Vortex lot report dataset: nine reports across eight materials, in a file generated on 22 October 2026. The dataset is a subset of /coa/, and some lots have no published report.
| Question | Answer across the nine reports |
|---|---|
| Which lab? | Two independent labs: ILS Laboratories, San Diego, CA (8 reports) and Freedom Diagnostics (1) |
| Who sent the sample? | 2 reports were commissioned in Vortex’s name: the 50 mg GHK-Cu lot and the 10 mg MOTS-c lot. 7 were issued to a partner facility for its own lot and are labelled “Partner facility” on /coa/ |
| Which lot, and when? | 8 of 9 carry a lot code; on the ninth (MOTS-c) the lot is given as a cap colour. Test dates run from 20 June to 14 August 2026 |
| Which assays? | Three different panels sit under the same word “tested”: 7 assays on 7 reports, 6 on the MOTS-c report, 3 on the GHK-Cu 50 mg report |
| Identity method? | Mass spectrometry (LC-MS) on 1 report; HPLC retention time on 8 |
| Where is the record? | 9 of 9 link to a record on the issuing lab’s own domain, and all nine matched the dataset’s lot, date, purity and net content when opened on 22 October 2026 |
Source: coa_reports.json, dataset generated 2026-10-22 (doi:10.5281/zenodo.23578844).
Three points follow. First, the word “tested” covered between three and seven assays across these nine reports, so the panel has to be read report by report. Second, most of these reports were ordered by the facility that supplied the lot, which means the link to Vortex stock rests on the lot code and Vortex’s statement that it carries that lot. Third, mass-spectrometry identity is the exception here, not the rule. Each of these is a reason the five questions exist, and each is visible because the reports are labelled and linked. The questions above are one part of a broader supplier evaluation checklist.
Frequently asked questions
What does third-party tested mean for research peptides?
It means a laboratory independent of the manufacturer and the seller analysed a sample from a named lot and issued a report it can confirm from its own records. The claim is complete when it names the lab, the requester, the lot, the assays and their methods, and the location of the lab’s record.
Is a partner-facility report third-party testing?
Yes, if the lab is independent: the facility ordered the test, but an outside lab ran it. The difference is in the chain to the vial. The report names the facility’s lot, so the link to a seller’s stock rests on the lot code and the seller’s records, and it should be labelled as a partner-facility report.
Does a third-party tested label cover the lot in hand?
Only if the lot code on the report matches the lot on the vial or its paperwork. A report describes the lot named on it, on its test date. Later lots under different codes need their own reports.
Is ISO/IEC 17025 accreditation required for third-party testing?
No, but it is a useful signal. It means an outside body has assessed the lab against the standard for the methods listed in its scope. The useful check is whether the specific methods on a report fall inside that scope.
References
- Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64-71. PMID 2675315. doi:10.1126/science.2675315
- Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. PMID 19750489. doi:10.1002/psc.1167
- Mant CT, Cepeniene D, Hodges RS. Reversed-phase HPLC of peptides: assessing column and solvent selectivity on standard, polar-embedded and polar endcapped columns. J Sep Sci. 2010;33(19):3005-21. PMID 21038458. doi:10.1002/jssc.201000518
- D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014;101:2-30. PMID 25044089. doi:10.1016/j.jpba.2014.06.012
Methods note: written by the Vortex Research Editorial Team. Dataset figures were computed directly from coa_reports.json (generated 2026-10-22). Literature was selected from PubMed for analytical and quality-control topics, and every PMID was checked against its PubMed record for title, journal and year. ISO/IEC 17025 is cited by name.
Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.
Peptide Testing Labs: Methods, Accreditation and Report VerificationWhat independent analytical labs do for peptides: the methods they run, what ISO/IEC 17025 accreditation does and does not cover, chain of custody and…Read article →
Bioburden Testing: USP <61>, <62>, ISO 11737 and MycoplasmaA laboratory explainer on bioburden: what the USP and microbial tests and ISO 11737-1 measure, how bioburden differs from sterility, how mycoplasma is detected…Read article →
Certificate of Conformance vs COA: Lot and Batch Numbers ExplainedHow a certificate of conformance differs from a certificate of analysis, where the specification sheet and SDS fit, what lot and batch numbers mean,…Read article →